anti-IgG, Human Plasma, Low Endotoxin antibody product blog
Tags: Antibody; Polyclonal Antibody; IgG, Human Plasma, Low Endotoxin; anti-IgG, Human Plasma, Low Endotoxin antibody;
The IgG, Human Plasma, Low Endotoxin n/a (Catalog #MBS135428) is an Antibody produced from Host: Human; Source: Human plasma and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s IgG, Human Plasma, Low Endotoxin can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB). Researchers should empirically determine the suitability of the IgG, Human Plasma, Low Endotoxin n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Purified from normal serum by immobilized Protein An using low endotoxin methodology. The purified protein is sterile filtered and lyophilized from azide fee PBS. Prepared from serum shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests. >95 percent pure by SDS-PAGE and <1 EU/mg.
Aliquot: 1 x 50 mg
Volume: 8.0 ml before lyophilization
Specific Activity: Endotoxin content = 0.272 EU/mg by LAL method
Target Information: This antibody has been selected as an isotype control as it has no known specificity. Buffer: 0.015M K Phosphate; 0.027M Na Phosphate; 0.15M NaCl; pH 7.2
Extinction Coefficient: 1.36. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing IgG, Human Plasma, Low Endotoxin are readily searchable from our website. Different antibodies against the same target such as IgG, Human Plasma, Low Endotoxin may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.